Arteris, Inc. (NASDAQ:AIP – Get Free Report) CFO Nicholas B. Hawkins sold 5,000 shares of the company’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $8.76, for a total transaction of $43,800.00. Following the transaction, the chief financial officer now owns 184,977 shares of the company’s stock, valued at approximately $1,620,398.52. This trade represents a 2.63 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Arteris Stock Performance
Arteris stock opened at $9.22 on Thursday. The firm has a 50 day simple moving average of $7.71 and a 200-day simple moving average of $7.76. Arteris, Inc. has a 1-year low of $4.83 and a 1-year high of $9.54. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The stock has a market cap of $370.46 million, a price-to-earnings ratio of -9.60 and a beta of 1.25.
Analysts Set New Price Targets
Separately, Rosenblatt Securities restated a “buy” rating and set a $15.00 price target on shares of Arteris in a research report on Wednesday, November 6th.
Institutional Trading of Arteris
Hedge funds have recently made changes to their positions in the company. US Bancorp DE acquired a new stake in Arteris during the 3rd quarter worth approximately $34,000. The Manufacturers Life Insurance Company purchased a new position in shares of Arteris in the 2nd quarter valued at $86,000. Algert Global LLC purchased a new position in shares of Arteris in the 2nd quarter valued at $115,000. MetLife Investment Management LLC grew its position in shares of Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after buying an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in shares of Arteris in the 3rd quarter valued at $226,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
- Five stocks we like better than Arteris
- Insider Trades May Not Tell You What You Think
- ZJK Stock Skyrockets Following NVIDIA Partnership News
- 3 Stocks to Consider Buying in October
- Zscaler: A Textbook Buy-the-Dip Opportunity
- How to Read Stock Charts for Beginners
- 2 AI-Powered Platforms Disrupting the Finance Industry
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.